Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
https://www.reuters.com/markets/deals/polands-unimot-talks-buy-shells-stake-german-schwedt-refinery-sources-2023-09-25/Poland's Unimot (UNTP.WA) has emerged as one of the possible buyers of a 37.5% stake oil major Shell